PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
6 hedge funds and large institutions have $1.74M invested in PAVmed Inc. Series Z Warrant in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
7% more capital invested
Capital invested by funds: $1.63M → $1.74M (+$108K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$160K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$400 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$40 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$159K |
| 2 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
-$17K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.37M | -$159K | -397,470 | -11% |
|
|
LCS
2
Levin Capital Strategies
New York
| $262K | +$160K | +398,805 | +177% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $63K | -$2.17K | -5,431 | -3% |
|
|
MRCM
4
M&R Capital Management
Summit,
New Jersey
| $35K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $6K | +$40 | +100 | +0.8% |
|
|
LWAC
6
Laurel Wealth Advisors (California)
Solana Beach,
California
| – | -$17K | -45,000 | Closed |
|
|
7
Bank of America
Charlotte,
North Carolina
| – | +$400 | +1,000 | New |
|
PAVMZ Hedge Fund Activity: Q2 2019 in Review
6 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q2 2019, worth a combined $1.74M — up 6.6% from $1.63M a quarter earlier.
Fund positioning in PAVMZ was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $160K. The largest seller was Sabby Management, cutting an estimated $159K.
- 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $1.74M of PAVmed Inc. Series Z Warrant stock for Q2 2019, up 6.6% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q2 2019 and 1 closed out, a net change of 0 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q2 2019 was Levin Capital Strategies, an estimated $160K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q2 2019 was Sabby Management, an estimated $159K sold.
Based on aggregated 13F filings for Q2 2019.